Synthesis and evaluation of a folate-linked anti-cancer prodrug

Proceedings - 2012 International Conference on Biomedical Engineering and Biotechnology, iCBEB 2012

Volumn , Issue , 2012, Pages 1089-1092

  Du, Changli ^a   Tian, Junmei ^a   Wan, Shunan ^a   Cao, Jie ^a   Chi, Xuemei ^a   Gu, Yueqing ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

anti tumor; doxorubicin; folic acid; pH sensitive; target

Indexed keywords

ACTIVE TARGETING; ANTI-TUMORS; ANTICANCER DRUG; CELL LINES; CLINICAL USE; DOXORUBICIN; ENHANCED PERMEABILITY AND RETENTION EFFECTS; FOLATE RECEPTOR; FOLIC ACIDS; FTIR; HIGH AFFINITY; PH SENSITIVE; PRODRUGS; SEPHADEX; SERUM ALBUMIN; TOXIC SIDE EFFECTS; TUMOR CELL LINES; TUMOR TARGETING; UV VISIBLE SPECTROSCOPY;

BIOMEDICAL ENGINEERING; BIOTECHNOLOGY; ION EXCHANGE; MASS SPECTROMETRY; ORGANIC ACIDS; TARGETS; TUMORS; ULTRAVIOLET VISIBLE SPECTROSCOPY;

CELL CULTURE;

EID: 84866648511     PISSN: None     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1109/iCBEB.2012.388     Document Type: Conference Paper

References (13)

1. D NM, X Y, G J, et al, "Attenuation of doxorubicin-induced cardiac injury by mitochondrial glutaredoxin", Biochim Biophys Acta, 1793,2009, 427-438.
2. Alexander RP, Bates RW, Rratt AJ, et al, "A N- nitrosochloroethylcephalosporin carbamate prodrug for antibody-directed enzyme prodrug therapy", Tetrahedron, 52(16), 1997, 5983-5988.
3. Xu LJ, Jin L, Pan H, et al, "Deferiprone protects the isolated atria from cardiotoxicity induced by doxorubicin", Acta Pharmacol Sin, 27, 2006, 1333-1339.
4. Fard MH, Bodhankar SL, Dikshit M, "Cardioprotective activity of fruit of Lagenaria Siceraria", Int J Pharmacol, 4(6), 2008, 466-471.
5. Sudimack J, Lee RJ, "Targeted drug delivery via the folate receptor", Adv Drug Deliv Rev, 41, 2002, 147-162.
6. Lu Y, Low PS, "Folate-mediated delivery of macromolecular anticancer therapeutic agent", Adv Drug Deliv Rev, 54, 2002, 675-693.
7. Paulos CM, Turk MJ, Breur GJ, et al, "Folate receptor mediated targeting of therapeutic and imaging agents to activated macrophages in rheumatoid arthritis", Adv Drug Deliv, 56, 2004, 1205-1217.
8. Kim D, Lee ES, Park K, et al, "Doxorubicin loaded pH-sensitive micelle: antitumoral efficacy against ovarian A2780/DOXR tumor", Pharm Res, 25, 2008, 2074-2082.
9. Pan XQ, Wang H, Lee RJ, "Antitumor activity of folate receptor-targeted liposomal doxorubicin in a KB oral carcinoma murine xenograft model", Pharm Res, 20, 2003, 417-422.
10. Mueller BM, Wrasidlo WA, Reisfeld RA, "Antibody conjugates with morpholinodoxorubicin and acid-cleavable linkers", Bioconjug Chem, 1, 1990, 325-330.
11. Shen WT, Ryser HJP, "Cis-aconityl spacer between daunomycin and macromolecular carriers: A model of pH-sensitive linkage releasing drug from a lysosomatropic conjugate", Biochem Biophys Res Commun, 102, 1981, 1048-1054.
12. Yoo HS, Lee EA, Park TG, "Doxorubicin-conjugate biodegradable polymeric micelles having acid-cleavable linkages", J Control Release, 82, 2002, 17-27.
13. Turek JJ, Leamon CP, Low PS, "Endocytosis of folate-protein conjugates: ultrastructural localization in KB cells", J Cell Sci, 106, 1993, 423-430.